Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles.
Published May 22, 2014 · K. Santos, M. Laranjo, A. Abrantes
European journal of medicinal chemistry
Q2 SJR score
30
Citations
0
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeaway6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles show potential as anticancer agents for triple-negative breast cancer, particularly in treating HCC1806 cells.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
···
···
···
···